ID   PAR11_HUMAN             Reviewed;         331 AA.
AC   Q9NR21; B4DRQ0; Q68DS1; Q8N5Y9;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 117.
DE   RecName: Full=Poly [ADP-ribose] polymerase 11;
DE            Short=PARP-11;
DE            EC=2.4.2.30;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 11;
DE            Short=ARTD11;
GN   Name=PARP11; Synonyms=C12orf6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Lorenz B., Strom T.M.;
RT   "Transcripts in human map region 12p13.3.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Bone marrow, and Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, MONO-ADP-RIBOSYLATION, AND MUTAGENESIS
RP   OF TYR-31; PHE-41; TYR-77; GLN-86; ARG-95 AND GLY-198.
RX   PubMed=25673562; DOI=10.1095/biolreprod.114.123661;
RA   Meyer-Ficca M.L., Ihara M., Bader J.J., Leu N.A., Beneke S.,
RA   Meyer R.G.;
RT   "Spermatid head elongation with normal nuclear shaping requires ADP-
RT   ribosyltransferase PARP11 (ARTD11) in mice.";
RL   Biol. Reprod. 92:80-80(2015).
RN   [9]
RP   STRUCTURE BY NMR OF 15-103.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of WWE domain in poly (ADP-ribose) polymerase
RT   family, member 11 (PARP11).";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Plays a role in nuclear envelope stability and nuclear
CC       remodeling during spermiogenesis (By similarity). In vitro,
CC       exhibits mono(ADP-ribosyl) transferase activity (PubMed:25673562).
CC       {ECO:0000250|UniProtKB:Q8CFF0, ECO:0000269|PubMed:25673562}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397}.
CC   -!- INTERACTION:
CC       Q969Y2:GTPBP3; NbExp=3; IntAct=EBI-748917, EBI-740290;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:25673562}. Note=Colocalizes with NUP153 at
CC       nuclear pores. {ECO:0000269|PubMed:25673562}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NR21-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NR21-2; Sequence=VSP_022553, VSP_022554;
CC       Name=3;
CC         IsoId=Q9NR21-4; Sequence=VSP_040378;
CC   -!- PTM: In vitro, can undergo mono-ADP-ribosylation.
CC       {ECO:0000269|PubMed:25673562}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH17569.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH31073.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF263540; AAF91391.1; -; mRNA.
DR   EMBL; AK299372; BAG61362.1; -; mRNA.
DR   EMBL; CR749294; CAH18149.1; -; mRNA.
DR   EMBL; AC005842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471116; EAW88853.1; -; Genomic_DNA.
DR   EMBL; BC017569; AAH17569.1; ALT_INIT; mRNA.
DR   EMBL; BC031073; AAH31073.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS66281.1; -. [Q9NR21-2]
DR   CCDS; CCDS8523.2; -. [Q9NR21-4]
DR   RefSeq; NP_001273450.1; NM_001286521.1. [Q9NR21-2]
DR   RefSeq; NP_001273451.1; NM_001286522.1. [Q9NR21-2]
DR   RefSeq; NP_065100.2; NM_020367.5. [Q9NR21-4]
DR   RefSeq; XP_005253768.1; XM_005253711.4. [Q9NR21-1]
DR   RefSeq; XP_011519272.1; XM_011520970.1. [Q9NR21-1]
DR   RefSeq; XP_011519273.1; XM_011520971.2. [Q9NR21-1]
DR   RefSeq; XP_011519275.1; XM_011520973.2. [Q9NR21-1]
DR   RefSeq; XP_016875159.1; XM_017019670.1. [Q9NR21-1]
DR   RefSeq; XP_016875160.1; XM_017019671.1. [Q9NR21-2]
DR   UniGene; Hs.657268; -.
DR   PDB; 2DK6; NMR; -; A=15-103.
DR   PDBsum; 2DK6; -.
DR   ProteinModelPortal; Q9NR21; -.
DR   SMR; Q9NR21; -.
DR   BioGrid; 121365; 11.
DR   IntAct; Q9NR21; 9.
DR   MINT; MINT-1446506; -.
DR   STRING; 9606.ENSP00000228820; -.
DR   ChEMBL; CHEMBL2380189; -.
DR   iPTMnet; Q9NR21; -.
DR   PhosphoSitePlus; Q9NR21; -.
DR   DMDM; 74734315; -.
DR   PaxDb; Q9NR21; -.
DR   PRIDE; Q9NR21; -.
DR   DNASU; 57097; -.
DR   Ensembl; ENST00000228820; ENSP00000228820; ENSG00000111224. [Q9NR21-4]
DR   Ensembl; ENST00000427057; ENSP00000397058; ENSG00000111224. [Q9NR21-2]
DR   Ensembl; ENST00000447133; ENSP00000405385; ENSG00000111224. [Q9NR21-2]
DR   GeneID; 57097; -.
DR   KEGG; hsa:57097; -.
DR   UCSC; uc001qml.4; human. [Q9NR21-1]
DR   CTD; 57097; -.
DR   DisGeNET; 57097; -.
DR   GeneCards; PARP11; -.
DR   HGNC; HGNC:1186; PARP11.
DR   HPA; HPA026895; -.
DR   MIM; 616706; gene.
DR   neXtProt; NX_Q9NR21; -.
DR   OpenTargets; ENSG00000111224; -.
DR   PharmGKB; PA25507; -.
DR   eggNOG; ENOG410IJ12; Eukaryota.
DR   eggNOG; ENOG4110TY6; LUCA.
DR   GeneTree; ENSGT00760000119084; -.
DR   HOGENOM; HOG000237349; -.
DR   HOVERGEN; HBG056772; -.
DR   InParanoid; Q9NR21; -.
DR   KO; K15259; -.
DR   OMA; DTNIQCS; -.
DR   OrthoDB; EOG091G14UY; -.
DR   PhylomeDB; Q9NR21; -.
DR   TreeFam; TF338389; -.
DR   BRENDA; 2.4.2.30; 2681.
DR   ChiTaRS; PARP11; human.
DR   EvolutionaryTrace; Q9NR21; -.
DR   GenomeRNAi; 57097; -.
DR   PRO; PR:Q9NR21; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000111224; -.
DR   CleanEx; HS_PARP11; -.
DR   ExpressionAtlas; Q9NR21; baseline and differential.
DR   Genevisible; Q9NR21; HS.
DR   GO; GO:0005635; C:nuclear envelope; IDA:MGI.
DR   GO; GO:0005643; C:nuclear pore; IEA:UniProtKB-SubCell.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:MGI.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0006998; P:nuclear envelope organization; IEA:Ensembl.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0007283; P:spermatogenesis; IEA:UniProtKB-KW.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   InterPro; IPR004170; WWE-dom.
DR   Pfam; PF00644; PARP; 1.
DR   Pfam; PF02825; WWE; 1.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
DR   PROSITE; PS50918; WWE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Alternative splicing;
KW   Complete proteome; Differentiation; Glycosyltransferase;
KW   mRNA transport; NAD; Nuclear pore complex; Nucleus; Protein transport;
KW   Reference proteome; Spermatogenesis; Transferase; Translocation;
KW   Transport.
FT   CHAIN         1    331       Poly [ADP-ribose] polymerase 11.
FT                                /FTId=PRO_0000273419.
FT   DOMAIN       15     99       WWE. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00248}.
FT   DOMAIN      116    331       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   VAR_SEQ       1     74       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_022553.
FT   VAR_SEQ       1      1       M -> MWEANPEM (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_040378.
FT   VAR_SEQ      75     82       FSYKIDFA -> MWEVAHVS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_022554.
FT   MUTAGEN      31     31       Y->A: No effect on subcellular location
FT                                at the nuclear envelope.
FT                                {ECO:0000269|PubMed:25673562}.
FT   MUTAGEN      41     41       F->A: No effect on subcellular location
FT                                at the nuclear envelope.
FT                                {ECO:0000269|PubMed:25673562}.
FT   MUTAGEN      77     77       Y->A: Loss of subcellular location at the
FT                                nuclear envelope.
FT                                {ECO:0000269|PubMed:25673562}.
FT   MUTAGEN      86     86       Q->A: Loss of subcellular location at the
FT                                nuclear envelope.
FT                                {ECO:0000269|PubMed:25673562}.
FT   MUTAGEN      95     95       R->A: Loss of subcellular location at the
FT                                nuclear envelope.
FT                                {ECO:0000269|PubMed:25673562}.
FT   MUTAGEN     198    198       G->W: No effect on subcellular location
FT                                at the nuclear envelope.
FT                                {ECO:0000269|PubMed:25673562}.
FT   STRAND       27     31       {ECO:0000244|PDB:2DK6}.
FT   STRAND       34     36       {ECO:0000244|PDB:2DK6}.
FT   STRAND       44     46       {ECO:0000244|PDB:2DK6}.
FT   HELIX        53     62       {ECO:0000244|PDB:2DK6}.
FT   STRAND       66     72       {ECO:0000244|PDB:2DK6}.
FT   STRAND       75     80       {ECO:0000244|PDB:2DK6}.
FT   TURN         81     84       {ECO:0000244|PDB:2DK6}.
FT   STRAND       85     91       {ECO:0000244|PDB:2DK6}.
FT   STRAND       94    102       {ECO:0000244|PDB:2DK6}.
SQ   SEQUENCE   331 AA;  38739 MW;  732A46ABC0456E7E CRC64;
     MFHKAEELFS KTTNNEVDDM DTSDTQWGWF YLAECGKWHM FQPDTNSQCS VSSEDIEKSF
     KTNPCGSISF TTSKFSYKID FAEMKQMNLT TGKQRLIKRA PFSISAFSYI CENEAIPMPP
     HWENVNTQVP YQLIPLHNQT HEYNEVANLF GKTMDRNRIK RIQRIQNLDL WEFFCRKKAQ
     LKKKRGVPQI NEQMLFHGTS SEFVEAICIH NFDWRINGIH GAVFGKGTYF ARDAAYSSRF
     CKDDIKHGNT FQIHGVSLQQ RHLFRTYKSM FLARVLIGDY INGDSKYMRP PSKDGSYVNL
     YDSCVDDTWN PKIFVVFDAN QIYPEYLIDF H
//
